Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666432 · ClinicalTrials.gov registry record
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 3,500
- Enrollment target
NCT00666432: Completed study, sponsored by University of Maryland, Baltimore.
NCT00666432 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 3,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666432 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 3,500 participants
- Enrollment target
Study Summary
Briefly, this multisite study is designed to identify endophenotypes (i.e., heritable biomarkers) associated with either schizophrenia or bipolar disorder alone, or both together. The subsequent genetic analyses will search genomic loci and candidate genes associated with each of the independent endophenotypes. This is a five site study that is slotted for NIMH funding.
Interventions
- OTHER This is an observational study model that is family based
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2008-05 |
| Est. Completion | 2019-11-22 |
What the finished NCT00666432 record still lists
NCT00666432 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which This is an observational study model that is family based is the first listed.
NCT00666432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00666432 about?
NCT00666432 is a clinical study titled "Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes". Briefly, this multisite study is designed to identify endophenotypes (i.e., heritable biomarkers) associated with either schizophrenia or bipolar disorder alone, or both together. The subsequent genetic analyses will search genomic loci and candidate genes associated with each of the independent end...
What is the current status of trial NCT00666432?
This trial is currently completed. The enrollment target is 3,500 participants. The study started on 2008-05. Estimated completion is 2019-11-22.
What interventions are being tested in trial NCT00666432?
The interventions under investigation include: This is an observational study model that is family based (OTHER).
Who is sponsoring clinical trial NCT00666432?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia